The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Effects of Different Blood Pressure–Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus: Results of Prospectively Designed Overviews of Randomized Trials
Open accessAbstract
BACKGROUND: Blood pressure (BP) level is a major determinant of cardiovascular morbidity and mortality in individuals with diabetes mellitus. Several guidelines recommend lower BP goals and specific drug classes for these patients. The overviews reported herein were performed to formally compare the effects on cardiovascular events and death of different BP-lowering regimens in individuals with and without diabetes. METHODS: Twenty-seven randomized trials (N = 158 709 participants) that included 33 395 individuals with diabetes and 125 314 without diabetes contributed to these analyses. For each outcome and each comparison summary, estimates of effect and 95% confidence intervals were calculated for patients with and without diabetes using a random-effects model. The constancy of the effects of each treatment regimen in participants with and without diabetes was examined using chi(2) tests of homogeneity. RESULTS: Total major cardiovascular events were reduced to a comparable extent in individuals with and without diabetes by regimens based on angiotensin-converting enzyme inhibitors, calcium antagonists, angiotensin receptor blockers, and diuretics/beta-blockers (P > .19 for all by chi(2) test of homogeneity). There was limited evidence that lower BP goals produced larger reductions in total major cardiovascular events in individuals with vs without diabetes (P = .03 by chi(2) test of homogeneity). CONCLUSIONS: These overviews showed that the short- to-medium-term effects on major cardiovascular events of the BP-lowering regimens studied were broadly comparable for patients with and without diabetes. Different effects of regimens on intermediate renal outcomes not evaluated in these overviews may still provide a rationale for using specific drug classes in patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Evidence-Based Eye Care · doi:10.1097/00132578-200307000-00027 · Cited by 1,793
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Wild, S. H., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2569-a · Cited by 1,477
Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & de Faire, U. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,447
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., & McG Thom, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001683 · Cited by 1,272
Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., & Ruilope, L. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02527-7 · Cited by 1,209
Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,166
Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., Brown, M. A., Jennings, G. L. R., Johnston, C. I., McNeil, J. J., Macdonald, G. J., Marley, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021716 · Cited by 1,130
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Schrier, R. W., Estacio, R. O., Esler, A., & Mehler, P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00213.x · Cited by 851
Black, H. R. (2003) · JAMA · doi:10.1001/jama.289.16.2073 · Cited by 748
Blood Pressure Lowering Treatment Trialists’ Collaboration
Neal, B. C. (2001) · Cited by 685
Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events
Pitt, B., Byington, R. P., Furberg, C. D., Hunninghake, D. B., Mancini, G. B. J., Miller, M. E., Riley, W., & (for the PREVENT Investigators) (2000) · Circulation · doi:10.1161/01.cir.102.13.1503 · Cited by 669
Zanchetti, A., Bond, M. G., Hennig, M., Neiss, A., Mancia, G., Dal Palù, C., Hansson, L., Magnani, B., Rahn, K.-H., Reid, J. L., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039288.86470.dd · Cited by 514
Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J.-L., Drury, P. L., Esmatjes, E., Hricik, D., Parikh, C. R., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00010 · Cited by 402
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials
Collins, R., & MacMahon, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03651-5 · Cited by 337
Dahlof, B., Devereux, B. R., & Kjeldsen, S. E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00777-8 · Cited by 311
Pitt, B., O’Neill, B., Feldman, R., Ferrari, R., Schwartz, L., Mudra, H., Bass, T., Pepine, C., Texter, M., Haber, H., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01461-8 · Cited by 231
Diabetes-related morbidity and mortality in a national sample of U.S. elders
Bertoni, A. G., Krop, J. S., Anderson, G. F., & Brancati, F. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.471 · Cited by 230
Wright, J. T., Bakris, G., & Greene, T. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00035-7 · Cited by 158
Yui, Y., Sumiyoshi, T., Kodama, K., Hirayama, A., Nonogi, H., Kanmatsuse, K., Origasa, H., Iimura, O., Ishii, M., Saruta, T., et al. (2004) · Hypertension Research · doi:10.1291/hypres.27.181 · Cited by 145
The Asia Pacific Cohort Studies Collaboration
Woodward, M., & Martiniuk, A. L. C. (2003) · Cited by 127
Kjeldsen, S. E. (2004) · Heart Drug · doi:10.1159/000076263 · Cited by 84
Black, H. R., Elliott, W. J., Granditis, G. A., & Grambsch, P. M. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00275-7 · Cited by 35
Dens, J. A., Desmet, W. J., Coussement, P. K., Scheerder, I. K. D., Kostopoulos, K. G., Kerdsinchai, P., Supanantaroek, C., & Piessens, J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01267-4 · Cited by 34
Berl, T., Hunsicker, L. G., & Lewis, J. B. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00276-9 · Cited by 23
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Metadata
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2005-06-27
- Volume
- 165
- Issue
- 12
- Pages
- 1410
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1782778410
- Cited by
- 793
- References
- 36
- FWCI
- 45.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.